Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Stage IIB Skin Melanoma

Known as: Stage IIB Melanoma of Skin, Stage IIB Skin Melanoma AJCC v6, Stage IIB Skin Melanoma AJCC v7 
Stage IIB includes: (T3b, N0, M0); (T4a, N0, M0). T3b: Cutaneous melanoma with a tumor measuring 2.01-4.0 mm in thickness, with ulceration. T4a… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Many follow‐up guidelines for patients with high‐risk melanoma include expensive imaging studies, serum biomarkers and regular… Expand
2019
2019
Malignant melanoma is a serious disease, the incidence of which rises. Since the most important treatment method is sufficient… Expand
2017
2017
Interferon-α (INF-α) is used as an adjuvant treatment for high-risk cutaneous melanoma. It has a large variety of potentially… Expand
2015
2015
We report here the first case of a misleading association of Clostridium difficile infection (CDI) with ipilimumab-related immune… Expand
2013
2013
PURPOSE The therapeutic efficacy of a synthetic parasite-derived peptide GK1, an immune response booster, was evaluated in a… Expand
2008
2008
The immunosuppressive impact of melanoma upon the human body is now beginning to be understood and interferon α2b at high dosage… Expand
1978
1978
A prospective trial with concurrent controls was designed to assess the effects of specific active immunotherapy in patients… Expand
  • table I
  • figure 1
  • figure 2
  • figure 3
1978
1978
Fifteen patients undergoing surgery for Stage IIb malignant melanoma were randomly allocated either to a group who received a… Expand
  • table II
1977
1977
The prognosis for patients who undergo surgery for stage IIB malignant melanoma is poor. Animal studies have suggested that BCG… Expand
1977
1977
The prognosis for patients who undergo surgery for stage IIB malignant melanoma is poor. Animal studies have suggested that BCG… Expand